Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 1261 AL 1275

Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia

Wills J, Jones J, Haggerty T, Duka V, Joyce JN, Sidhu A.

Exp Neurol. 2010 Sep;225(1):210-8. doi: 10.1016/j.expneurol.2010.06.017. Epub 2010 Jun 28.

Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity

Weinreb O, Amit T, Bar-Am O, Youdim MB.

Prog Neurobiol. 2010 Nov;92(3):330-44. doi: 10.1016/j.pneurobio.2010.06.008. Epub 2010 Jun 19.

Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: implications for mitochondrial dysfunction in Parkinson disease

Bisaglia M, Soriano ME, Arduini I, Mammi S, Bubacco L.

Biochim Biophys Acta. 2010 Sep;1802(9):699-706. doi: 10.1016/j.bbadis.2010.06.006. Epub 2010 Jun 18.

Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish

Sallinen V, Kolehmainen J, Priyadarshini M, Toleikyte G, Chen YC, Panula P.

Neurobiol Dis. 2010 Oct;40(1):93-101. doi: 10.1016/j.nbd.2010.06.001. Epub 2010 Jun 18.

Surgical approaches to treatment of Parkinson's disease: Implications for speech function

Murdoch BE.

Int J Speech Lang Pathol. 2010 Oct;12(5):375-84. doi: 10.3109/17549507.2010.495785.

(S)-5-Methoxymethyl-3-[6-(4,4,4-trifluorobutoxy)benzo[d]isoxazol-3-yl]-oxazolidin-2-[(11)C]one

Leung K.

2010 May 22 [updated 2010 Jul 7]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

High compliance with rotigotine transdermal patch in the treatment of idiopathic Parkinson's disease

Schnitzler A, Leffers KW, Häck HJ.

Parkinsonism Relat Disord. 2010 Sep;16(8):513-6. doi: 10.1016/j.parkreldis.2010.06.009. Epub 2010 Jul 4.

EMAS position statement: Managing women with premature ovarian failure

Vujovic S, Brincat M, Erel T, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Tremollieres F, Rozenberg S, Rees M; European Menopause and Andropause Society.

Maturitas. 2010 Sep;67(1):91-3. doi: 10.1016/j.maturitas.2010.04.011. Epub 2010 Jun 3.

Elevated levels of methylmalonate and homocysteine in Parkinson's disease, progressive supranuclear palsy and amyotrophic lateral sclerosis

Levin J, Bötzel K, Giese A, Vogeser M, Lorenzl S.

Dement Geriatr Cogn Disord. 2010;29(6):553-9. doi: 10.1159/000314841. Epub 2010 Jul 3.

A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's disease

Muramatsu S, Fujimoto K, Kato S, Mizukami H, Asari S, Ikeguchi K, Kawakami T, Urabe M, Kume A, Sato T, Watanabe E, Ozawa K, Nakano I.

Mol Ther. 2010 Sep;18(9):1731-5. doi: 10.1038/mt.2010.135. Epub 2010 Jul 6.

MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration

Saugstad JA.

J Cereb Blood Flow Metab. 2010 Sep;30(9):1564-76. doi: 10.1038/jcbfm.2010.101. Epub 2010 Jul 7.

Successful birth of an IVF baby in a patient with Parkinson's disease

Asha B, Hansali N, Apoorva P.

J Hum Reprod Sci. 2010 Jan;3(1):42-3. doi: 10.4103/0974-1208.63123.

Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke

Hayakawa K, Mishima K, Fujiwara M.

Pharmaceuticals (Basel). 2010 Jul 8;3(7):2197-2212. doi: 10.3390/ph3072197.

[Non-motor fluctuations in Parkinson's disease]

Levin OS, Smolentseva IG, Ivanov AK.

Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(3):90-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias